Fig 5. TCS1102 has no effect on cue/nicotine compound reinstatement after short-term self-administration.

(A) In a separate cohort of rats (n = 14) trained for 15 days, cue/nicotine primed reinstatement was not affected by central administration of 10 or 30 μg of TCS1102. (B) TCS1102 also had no effect on active nosepokes over the course of the session. Data are means ± SEM.